David Fulton

2.7k total citations · 1 hit paper
13 papers, 2.3k citations indexed

About

David Fulton is a scholar working on Molecular Biology, Physiology and Surgery. According to data from OpenAlex, David Fulton has authored 13 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Physiology and 3 papers in Surgery. Recurrent topics in David Fulton's work include Nitric Oxide and Endothelin Effects (6 papers), Angiogenesis and VEGF in Cancer (3 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). David Fulton is often cited by papers focused on Nitric Oxide and Endothelin Effects (6 papers), Angiogenesis and VEGF in Cancer (3 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). David Fulton collaborates with scholars based in United States, Greece and Netherlands. David Fulton's co-authors include William C. Sessa, Kenneth Walsh, Yasuko Kureishi, Zhengyu Luo, David J. Lefer, Ann Bialik, Ichiro Shiojima, Timothy J. McCabe, Linda J. Roman and Jean‐Philippe Gratton and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and The FASEB Journal.

In The Last Decade

David Fulton

13 papers receiving 2.2k citations

Hit Papers

The HMG-CoA reductase inhibitor simvastatin activates the... 2000 2026 2008 2017 2000 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.
    2000 1.2k citations Yasuko Kureishi, Zhengyu Luo et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Fulton United States 11 1.0k 638 534 458 353 13 2.3k
Denis deBlois Canada 29 1.2k 1.2× 469 0.7× 521 1.0× 855 1.9× 359 1.0× 75 3.2k
Eileen M. Redmond United States 34 1.4k 1.4× 576 0.9× 600 1.1× 488 1.1× 327 0.9× 82 3.2k
Michael B. Stemerman United States 25 863 0.8× 577 0.9× 591 1.1× 493 1.1× 266 0.8× 48 2.5k
Stephan Goetze Germany 22 1.3k 1.3× 261 0.4× 362 0.7× 396 0.9× 385 1.1× 38 2.1k
Peter Kuhlencordt Germany 24 988 1.0× 388 0.6× 802 1.5× 593 1.3× 307 0.9× 36 2.5k
Motohide Isono Japan 26 1.6k 1.6× 340 0.5× 376 0.7× 454 1.0× 185 0.5× 43 3.6k
Kerri Thai Canada 33 1.4k 1.4× 532 0.8× 303 0.6× 790 1.7× 151 0.4× 63 3.0k
Hidetsugu Matsushita Japan 19 694 0.7× 351 0.6× 308 0.6× 323 0.7× 339 1.0× 27 1.8k
Sunny H. Zhang United States 11 846 0.8× 803 1.3× 281 0.5× 428 0.9× 300 0.8× 12 2.4k
Masako Mitsumata Japan 29 925 0.9× 471 0.7× 228 0.4× 336 0.7× 415 1.2× 65 2.5k

Countries citing papers authored by David Fulton

Since Specialization
Citations

This map shows the geographic impact of David Fulton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Fulton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Fulton more than expected).

Fields of papers citing papers by David Fulton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Fulton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Fulton. The network helps show where David Fulton may publish in the future.

Co-authorship network of co-authors of David Fulton

This figure shows the co-authorship network connecting the top 25 collaborators of David Fulton. A scholar is included among the top collaborators of David Fulton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Fulton. David Fulton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Varadarajan, Sudhahar, Ryan A. Harris, Archita Das, et al.. (2022). Exercise improves angiogenic function of circulating exosomes in type 2 diabetes: Role of exosomal SOD3. The FASEB Journal. 36(3). e22177–e22177. 37 indexed citations
2.
Fulton, David, et al.. (2014). Olympus TLP – Challenges and Considerations of Designing a Deepwater Venture for a 45 year Production Life. Offshore Technology Conference. 2 indexed citations
3.
Zhu, Shu, Darren D. Browning, Richard E. White, David Fulton, & Scott A. Barman. (2009). Mutation of protein kinase C phosphorylation site S1076 on α-subunits affects BKCachannel activity in HEK-293 cells. American Journal of Physiology-Lung Cellular and Molecular Physiology. 297(4). L758–L766. 10 indexed citations
4.
Pandey, Deepesh & David Fulton. (2008). Regulation of NADPH oxidase 5 activity by PKC and MAPK pathways.. The FASEB Journal. 22(S1). 1 indexed citations
5.
Tsigkos, Stelios, Zongmin Zhou, Αναστασία Κοτανίδου, et al.. (2006). Regulation of Ang2 release by PTEN/PI3‐kinase/Akt in lung microvascular endothelial cells. Journal of Cellular Physiology. 207(2). 506–511. 25 indexed citations
6.
Platt, D., Manuela Bartoli, Azza B. El‐Remessy, et al.. (2005). Peroxynitrite increases VEGF expression in vascular endothelial cells via STAT3. Free Radical Biology and Medicine. 39(10). 1353–1361. 51 indexed citations
7.
Acevedo, Lisette M., Jun Yu, Hediye Erdjument‐Bromage, et al.. (2004). A new role for Nogo as a regulator of vascular remodeling. Nature Medicine. 10(4). 382–388. 207 indexed citations
8.
Iwakiri, Yasuko, Ming-Hung Tsai, Timothy J. McCabe, et al.. (2002). Phosphorylation of eNOS initiates excessive NO production in early phases of portal hypertension. American Journal of Physiology-Heart and Circulatory Physiology. 282(6). H2084–H2090. 63 indexed citations
9.
Gratton, Jean‐Philippe, Manuel Morales‐Ruiz, Yasuko Kureishi, et al.. (2001). Akt Down-regulation of p38 Signaling Provides a Novel Mechanism of Vascular Endothelial Growth Factor-mediated Cytoprotection in Endothelial Cells. Journal of Biological Chemistry. 276(32). 30359–30365. 243 indexed citations
10.
Mital, Seema, Xiao–Ping Zhang, Gong Zhao, et al.. (2000). Simvastatin upregulates coronary vascular endothelial nitric oxide production in conscious dogs. American Journal of Physiology-Heart and Circulatory Physiology. 279(6). H2649–H2657. 85 indexed citations
11.
McCabe, Timothy J., David Fulton, Linda J. Roman, & William C. Sessa. (2000). Enhanced Electron Flux and Reduced Calmodulin Dissociation May Explain “Calcium-independent” eNOS Activation by Phosphorylation. Journal of Biological Chemistry. 275(9). 6123–6128. 331 indexed citations
12.
Kureishi, Yasuko, Zhengyu Luo, Ichiro Shiojima, et al.. (2000). The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.. Nature Medicine. 6(9). 1004–1010. 1207 indexed citations breakdown →
13.
Fulton, David, Andreas Papapetropoulos, Xiao–Ping Zhang, et al.. (2000). Quantification of eNOS mRNA in the canine cardiac vasculature by competitive PCR. American Journal of Physiology-Heart and Circulatory Physiology. 278(2). H658–H665. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Denis deBlois Breakdown of academic impact, for papers by Eileen M. Redmond Breakdown of academic impact, for papers by Michael B. Stemerman Breakdown of academic impact, for papers by Stephan Goetze Breakdown of academic impact, for papers by Peter Kuhlencordt Breakdown of academic impact, for papers by Motohide Isono Breakdown of academic impact, for papers by Kerri Thai Breakdown of academic impact, for papers by Hidetsugu Matsushita Breakdown of academic impact, for papers by Sunny H. Zhang Breakdown of academic impact, for papers by Masako Mitsumata
Rankless by CCL
2026